Clinical Trials Logo

Stage III Breast Cancer AJCC v7 clinical trials

View clinical trials related to Stage III Breast Cancer AJCC v7.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03326258 Withdrawn - Metastatic Melanoma Clinical Trials

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Start date: April 20, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This phase Ib/II trial studies the best dose of glembatumumab vedotin when giving together with nivolumab and ipilimumab in treating patients with solid tumor that has spread to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as glembatumumab vedotin, nivolumab, and ipilimumab, may interfere with the ability of tumor cells to grow and spread.